Stockholders' Equity (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Stockholders Equity Note [Abstract] |
|
| Schedule of Common Stock Reserved for Future Issuance |
The Company had reserved shares of common stock for future issuance as shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
June 30,
2026 |
|
|
December 31,
2025 |
|
Shares of common stock reserved for future issuance upon exercise of outstanding warrants and pre-funded warrants |
|
|
19,100,800 |
|
|
|
19,100,800 |
|
Shares of common stock reserved for future issuance upon exercise under the Amended and Restated 2019 Stock Incentive Plan |
|
|
11,386,272 |
|
|
|
9,023,200 |
|
Shares of common stock reserved for future issuance under the 2019 Employee Stock Purchase Plan |
|
|
1,097,288 |
|
|
|
1,103,842 |
|
Shares of common stock reserved for future issuance upon exercise under the 2012 Stock Incentive Plan |
|
|
278,418 |
|
|
|
278,418 |
|
|
|
|
31,862,778 |
|
|
|
29,506,260 |
|
|
| Warrant Activity Including Activity Related To Pre-funded Warrants |
Warrants Warrant activity, including activity related to pre-funded warrants, is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
Pre-funded Warrant
Shares |
|
|
Number of
Common Stock Warrant
Shares |
|
|
Total Number of
Warrant
Shares |
|
|
Weighted
Average
Exercise
Price |
|
Outstanding as of December 31, 2025 |
|
|
17,248,948 |
|
|
|
1,851,852 |
|
|
|
19,100,800 |
|
|
$ |
0.13 |
|
Exercised |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
— |
|
Outstanding as of June 30, 2026 |
|
|
17,248,948 |
|
|
|
1,851,852 |
|
|
|
19,100,800 |
|
|
$ |
0.13 |
|
|
| Schedule of Share-based Compensation, Stock Options, Activity |
A summary of the Company’s combined stock option activity for the 2019 Plan and the 2012 Plan is as follows:
|
|
|
|
|
|
|
|
|
|
|
Number of
Option
Shares |
|
|
Weighted
Average
Exercise
Price |
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2025 |
|
|
9,301,618 |
|
|
$ |
3.63 |
|
Granted |
|
|
3,581,500 |
|
|
$ |
11.19 |
|
Exercised |
|
|
(768,273 |
) |
|
$ |
2.53 |
|
Forfeited |
|
|
(337,655 |
) |
|
$ |
6.73 |
|
Expired |
|
|
— |
|
|
$ |
— |
|
Outstanding as of June 30, 2026 |
|
|
11,777,190 |
|
|
$ |
5.91 |
|
Options exercisable as of June 30, 2026 |
|
|
5,920,713 |
|
|
$ |
3.80 |
|
Options unvested as of June 30, 2026 |
|
|
5,856,477 |
|
|
$ |
8.04 |
|
|
| Schedule of Stock-based Compensation Expenses Recognized |
The following table summarizes the classifications of stock-based compensation expenses for the 2012 Plan, the 2019 Plan and the 2019 ESPP recognized in the Condensed Consolidated Statements of Comprehensive Loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
|
|
Six Months Ended
June 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
General and administrative expense |
|
$ |
1,896 |
|
|
$ |
787 |
|
|
$ |
3,245 |
|
|
$ |
1,471 |
|
Research and development expense |
|
|
1,376 |
|
|
|
597 |
|
|
|
2,218 |
|
|
|
1,121 |
|
Total stock-based compensation expenses |
|
$ |
3,272 |
|
|
$ |
1,384 |
|
|
$ |
5,463 |
|
|
$ |
2,592 |
|
|